| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/29/2005 | CN1208054C Sustained releasing huperzine preparation |
| 06/29/2005 | CN1208053C Treatment of hemoglobinopathy |
| 06/29/2005 | CN1208052C Coenzyme Q10 precursor liposome and preparation method |
| 06/29/2005 | CN1208051C Medicine against spinal canal restenosis and use thereof |
| 06/29/2005 | CN1208047C Self-emulsifying formulation for lipophilic compounds |
| 06/28/2005 | US6912470 Nucleotide sequences coding enzymatic polypeptide for use in the production of anticarcinogenic and infection agents |
| 06/28/2005 | US6911555 Such as (1R,5R,6S)-(6-(aminomethyl)bicyclo(3.2.0)hept-6-yl) acetic acid cyclohexylamine salt via catalytic hydrogenation; for use as chemical intermediates in preparation of cyclic amino acids |
| 06/28/2005 | US6911549 Method of preparing a taxol derivative |
| 06/28/2005 | US6911545 Crystals of glucokinase and methods of growing them |
| 06/28/2005 | US6911543 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 06/28/2005 | US6911542 Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives |
| 06/28/2005 | US6911540 2′ Modified oligonucleotides |
| 06/28/2005 | US6911480 Methods for the inhibition of exoprotein production from Gram positive bacteria |
| 06/28/2005 | US6911479 Side effect reduction; purity; removal of stereoisomers |
| 06/28/2005 | US6911478 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 06/28/2005 | US6911476 Useful for potentiating glutamate receptor function therefore useful for treating a wide variety of conditions, such as psychiatric and neurological disorders |
| 06/28/2005 | US6911475 For producing a drug for continuous or progressive administration; has a second component comprising L-DOPA |
| 06/28/2005 | US6911474 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism |
| 06/28/2005 | US6911472 Pharmaceutical composition comprising a hmg-coa reductase inhibitor |
| 06/28/2005 | US6911471 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 06/28/2005 | US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity |
| 06/28/2005 | US6911468 Useful as a prophylactic or therapeutic agent for diabetes or the like |
| 06/28/2005 | US6911467 Useful for the treatment of type 2 diabetes, impaired glucose tolerance and certain other conditions |
| 06/28/2005 | US6911466 Amyloid precurser protein lowering agents used in preventing, delaying, or reversing the progression of Alzheimer's disease; identifying agents that increase or decrease the risk of developing Alzheimer's disease |
| 06/28/2005 | US6911465 For treating inflammatory diseases including rheumatoid arthritis, glomerular nephritides, lung fibrosis, restenosis, alveolitis, asthma, psoriasis, inflammatory bowel disease, multiple sclerosis and brain trauma, stroke, ischemia |
| 06/28/2005 | US6911464 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses |
| 06/28/2005 | US6911463 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity |
| 06/28/2005 | US6911462 Benzimidazole compounds for regulating IgE |
| 06/28/2005 | US6911461 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse |
| 06/28/2005 | US6911460 Antiviral agents and methods of treating viral infections |
| 06/28/2005 | US6911459 Pharmaceutical composition |
| 06/28/2005 | US6911458 Compounds |
| 06/28/2005 | US6911457 Diabetes imaging probes |
| 06/28/2005 | US6911456 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists |
| 06/28/2005 | US6911455 Use of pharmaceutically active agents known to cause histamine release when intravenously administered to an animal |
| 06/28/2005 | US6911454 By reversing or inhibiting the glycoprotein "pumps" associated with drug resistant cells |
| 06/28/2005 | US6911452 Central nervous system disorders, sleep disorders, eating disorders. sexual disorders, hypotensive agents |
| 06/28/2005 | US6911451 Phenylalanine derivatives |
| 06/28/2005 | US6911450 Pyrimidine acyclonucleoside derivatives, preparation method and use thereof |
| 06/28/2005 | US6911449 For treating osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinu -ria, aneurysmal aortic disease, dystrophobic epidermolysis, bullosa, conditions leading to inflammatory responses |
| 06/28/2005 | US6911448 Piperazine and piperidine compounds |
| 06/28/2005 | US6911447 Non-aromatic carbocyclic rings; aromatic carbocyclic rings; non-aromatic heterocyclic rings; aromatic heterocyclic rings; compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 |
| 06/28/2005 | US6911446 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds |
| 06/28/2005 | US6911445 For reatment of depression, childhood depression, dysthymia, anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder, attention deficit disorder, obsessive-compulsive disorder, cocaine and alcohol addiction |
| 06/28/2005 | US6911444 Non-steroidal IL-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors |
| 06/28/2005 | US6911443 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 06/28/2005 | US6911442 Has no toxicological effects; adapted for oral, topical or parenteral use and may be used for the treatment of bacterial infection in mammals |
| 06/28/2005 | US6911441 Prolonged release pharmaceutical composition |
| 06/28/2005 | US6911440 For the treatment of inflammatory rheumatic/rheumatoid diseases and/or pain, rheumatoid arthritis |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911438 Mixture of 2-hydroxyestrone and a substantially less amount of 17-beta estradiol |
| 06/28/2005 | US6911436 Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| 06/28/2005 | US6911435 Method of treating leukopenia with adenosine |
| 06/28/2005 | US6911434 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
| 06/28/2005 | US6911433 O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
| 06/28/2005 | US6911432 3,6-anhydrogalactopyranose compound; for use in inducing apoptosis, for prophylaxis and therapy of allergies, as antioxidant, as preservative in cosmetics |
| 06/28/2005 | US6911428 Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 06/28/2005 | US6911427 No-modified hemoglobins and uses therefore |
| 06/28/2005 | US6911424 2′-fluoronucleosides |
| 06/28/2005 | US6911342 Bioequivalence test for iron-containing formulations |
| 06/28/2005 | US6911320 Pituitary tumor transforming gene (PTTG), formerly pituitary tumor specific gene (PTTG) |
| 06/28/2005 | US6911217 Controlled release bead, a method of producing the same and multiple unit formulation comprising it |
| 06/28/2005 | US6911211 Pharmaceutical and cosmetic carrier or composition for topical application |
| 06/28/2005 | US6911210 Stable active ingredient combinations which are effective against blemished skin and against acne and contain interface-active glucose derivatives and hydroxycarbolic acids |
| 06/28/2005 | US6911209 Method of treating sick sinus syndrome with levosimendan |
| 06/28/2005 | US6911200 Administering a target cell-specific adenovirus vector, comprising an adenoviral gene essential for replication under transcriptional control of a target cell-specific transcriptional regulatory element and an anticancer agent |
| 06/28/2005 | US6911196 Boric Acid, Zinc oxide, Calamine, Cetrimide, Olive Oil, Castor Oil, Cod liver Oil, White Petroleum base, Salicylic Acid, and Tannic Acid |
| 06/28/2005 | US6911194 Skin preparation |
| 06/28/2005 | CA2402300C Fluorocarbon aerosol medicaments |
| 06/28/2005 | CA2350538C Pyrazolopyrimidinone derivatives for the treatment of impotence |
| 06/28/2005 | CA2332054C Platinum complex, its preparation and therapeutic application |
| 06/28/2005 | CA2319554C Quinoxalinones as serine protease inhibitors such as factor xa and thrombin |
| 06/28/2005 | CA2271196C Pharmaceutical compositions of hiv protease inhibitors with improved oral bioavailability |
| 06/28/2005 | CA2232230C Phosphopantetheinyl transferases and uses thereof |
| 06/28/2005 | CA2174106C Imidazo[1,5-a]quinolines for treatment of anxiety and sleep disorders |
| 06/28/2005 | CA2168097C Substituted 2-aminotetralins |
| 06/28/2005 | CA2159071C 4-arylisoindole analgesics |
| 06/28/2005 | CA2152280C Use of riluzole as a radiorestorer |
| 06/28/2005 | CA2146775C Novel vitamin d analogues |
| 06/28/2005 | CA2138110C Cosmetic and/or dermatologic composition containing salicylic acid derivatives and process for their solubilization |
| 06/24/2005 | CA2454456A1 Amino ceramide-like compounds and therapeutic methods of use |
| 06/23/2005 | WO2005057588A2 Granulated decontamination formulations |
| 06/23/2005 | WO2005057171A2 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 06/23/2005 | WO2005056837A2 Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
| 06/23/2005 | WO2005056812A2 Practical, cost-effective synthesis of ubiquinones |
| 06/23/2005 | WO2005056792A1 Long double-stranded rna for interference with lowered interferon response |
| 06/23/2005 | WO2005056741A1 Adhesion inhibition of micro organisms by non-ionic surfactants |
| 06/23/2005 | WO2005056708A2 Bioadhesive polymers with catechol functionality |
| 06/23/2005 | WO2005056607A1 PROCESS FOR PRODUCTION OF INCLUSION COMPLEXES OF VALSARTAN WITH β-CYCLODEXTRIN |
| 06/23/2005 | WO2005056594A1 Akt ACTIVITY SPECIFICALLY INHIBITING POLYPEPTIDE |
| 06/23/2005 | WO2005056572A2 Clustered multi-antigenic carbohydrate constructs, methods for their preparation and uses thereof |
| 06/23/2005 | WO2005056562A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds as ikk inhibitors |
| 06/23/2005 | WO2005056561A1 Microcrystal and medicinal preparation containing the same |
| 06/23/2005 | WO2005056554A2 Azepinoindole derivatives as pharmaceutical agents |
| 06/23/2005 | WO2005056552A1 Naphthyridine derivatives and their use as modulators of muscarinic receptors |
| 06/23/2005 | WO2005056549A1 Water-soluble etoposide analogs and methods of use thereof |
| 06/23/2005 | WO2005056547A2 Quinoxalines useful as inhibitors of protein kinases |
| 06/23/2005 | WO2005056546A1 Keto lactam compounds and use thereof |
| 06/23/2005 | WO2005056544A1 2- ( (2, 3-dihydroxypropyl) aminomethyl) chromane derivatives for use as beta-3 adrenoreceptor agonists in the treatment of urological and inflammatory disorders |
| 06/23/2005 | WO2005056542A1 Compositions comprising an hiv protease inhibitor |